560 related articles for article (PubMed ID: 22616572)
1. Predictive factors for residual disease in re-excision specimens after breast-conserving surgery.
Atalay C; Irkkan C
Breast J; 2012; 18(4):339-44. PubMed ID: 22616572
[TBL] [Abstract][Full Text] [Related]
2. Positive or close margins in breast conserving surgery: is re-excision always necessary?
Gurdal SO; Karanlik H; Cabioglu N; Ozcinar B; Yavuz E; Tuzlali S; Ozmen V
Eur J Surg Oncol; 2012 May; 38(5):399-406. PubMed ID: 22440741
[TBL] [Abstract][Full Text] [Related]
3. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
[TBL] [Abstract][Full Text] [Related]
4. Impact of Consensus Guidelines by the Society of Surgical Oncology and the American Society for Radiation Oncology on Margins for Breast-Conserving Surgery in Stages 1 and 2 Invasive Breast Cancer.
Chung A; Gangi A; Amersi F; Bose S; Zhang X; Giuliano A
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S422-7. PubMed ID: 26310280
[TBL] [Abstract][Full Text] [Related]
5. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
6. Margin width is not predictive of residual disease on re-excision in breast conserving therapy.
Hadzikadic Gusic L; McGuire KP; Ozmen T; Soran A; Thomas CR; McAuliffe PF; Diego EJ; Bonaventura M; Johnson RR; Ahrendt GM
J Surg Oncol; 2014 Apr; 109(5):426-30. PubMed ID: 24338603
[TBL] [Abstract][Full Text] [Related]
7. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
8. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ.
Wei S; Kragel CP; Zhang K; Hameed O
Hum Pathol; 2012 Jul; 43(7):986-93. PubMed ID: 22221704
[TBL] [Abstract][Full Text] [Related]
10. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
11. The role of reexcision for positive margins in optimizing local disease control after breast-conserving surgery for cancer.
Aziz D; Rawlinson E; Narod SA; Sun P; Lickley HL; McCready DR; Holloway CM
Breast J; 2006; 12(4):331-7. PubMed ID: 16848842
[TBL] [Abstract][Full Text] [Related]
12. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Residual Tumor in Breast-Conserving Therapy.
Rath MG; Uhlmann L; Heil J; Domschke C; Roth Z; Sinn HP; Marme F; Scharf A; Schneeweiss A; Kieser M; Sohn C; Rom J
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S451-8. PubMed ID: 26224405
[TBL] [Abstract][Full Text] [Related]
14. Triple negative breast cancer is associated with an increased risk of residual invasive carcinoma after lumpectomy.
Sioshansi S; Ehdaivand S; Cramer C; Lomme MM; Price LL; Wazer DE
Cancer; 2012 Aug; 118(16):3893-8. PubMed ID: 22864932
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment.
Milgrom S; Cody H; Tan L; Morrow M; Pesce C; Setton J; Rogers K; Arnold B; Eaton A; Catalano J; McCormick B; Powell S; Ho A
Ann Surg Oncol; 2012 Nov; 19(12):3762-70. PubMed ID: 22576064
[TBL] [Abstract][Full Text] [Related]
16. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
[TBL] [Abstract][Full Text] [Related]
17. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
18. Reexcision for positive margins in breast cancer: A predictive score of residual disease.
Mimouni M; Lecuru F; Rouzier R; Lotersztajn N; Heitz D; Cohen J; Fauconnier A; Huchon C
Surg Oncol; 2015 Sep; 24(3):129-35. PubMed ID: 26298198
[TBL] [Abstract][Full Text] [Related]
19. Intra-operative touch preparation cytology; does it have a role in re-excision lumpectomy?
Valdes EK; Boolbol SK; Cohen JM; Feldman SM
Ann Surg Oncol; 2007 Mar; 14(3):1045-50. PubMed ID: 17206481
[TBL] [Abstract][Full Text] [Related]
20. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]